Evidence map›Paper›PMID 19122467›Full record

ReviewOphthalmic research2009

The role of antimicrobial peptides at the ocular surface.

Alison M McDermott

Open access · bronzeAbstract readReview
In one paragraph

Review in Ophthalmic research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 132 citations in OpenAlex.

  1. Paucibacterial Microbiome and Resident DNA Virome of the Healthy Conjunctiva.Investigative ophthalmology & visual science · 2016
    Trial
  2. Short Synthetic Lipopeptides CAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Epithelial Heparan Sulfate PromotesProteoglycan research · 2025
    Article
  6. Article
  7. Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  8. Review
  9. Article
  10. Contact Lens Wear Alters Transcriptional Responses tobioRxiv : the preprint server for biology · 2024
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Innate Immune System Activation, Inflammation and Corneal Wound Healing.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Immunomodulatory and Allergenic Properties of Antimicrobial Peptides.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alison M McDermottCollege of Optometry, University of Houston, Houston, TX 77204, USA. amcdermott@optometry.uh.edu
University of Houston · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI VALLABH E DAS · 1988 to 2026
$16.4M
Role of Antimicrobial Peptides at the Ocular SurfaceR01EY013175 · NEI · UNIVERSITY OF HOUSTON · PI MCDERMOTT, ALISON M · 2001 to 2016
$4.3M
NEI NIH HHS EY007551NEI NIH HHS P30 EY007551NEI NIH HHS R01 EY013175
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) such as defensins and cathelicidins are small peptides with broad-spectrum activity against bacteria, fungi and viruses. In addition, several AMPs modulate mammalian cell behaviours including migration, proliferation and cytokine production. This review describes findings from recent studies showing the presence of various AMPs at the human ocular surface and discusses their mechanism of antimicrobial action and potential non-microbicidal roles. Corneal and conjunctival epithelial cells produce beta-defensins and the cathelicidin LL-37, whereas neutrophils, infiltrating in response to a specific stimulus, supply additional LL-37 as well as alpha-defensins. In vitro studies suggest that LL-37 and human beta-defensin-3 are the most likely to have significant independent antimicrobial activity, while other AMPs may act synergistically to help protect the ocular surface from invading pathogens. Current evidence also supports a role for some AMPs in modulating wound healing responses. Although yet to be brought to fruition, AMPs hold significant potential as therapeutic agents for the prophylaxis and treatment of infection, promotion of wound healing and immune modulation.

Indexed as

alpha-DefensinsAnimalsAnti-Infective AgentsAntimicrobial Cationic PeptidesConjunctivaCorneaEpithelial CellsHumansalpha-DefensinsAnti-Infective AgentsAntimicrobial Cationic Peptides

Identifiers

PMID19122467
PMCPMC3712804
OpenAlexW1512191088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.